Editas Medicine GAAP EPS of -$0.06 beats by $0.20, revenue of $24.74M beats by $15.97M
Source: SeekingAlpha
2026-03-09 07:02:45 ET
More on Editas Medicine
- Seeking Alpha’s Quant Rating on Editas Medicine
- Historical earnings data for Editas Medicine
- Financial information for Editas Medicine
Read the full article on Seeking Alpha
For further details see:
Editas Medicine GAAP EPS of -$0.06 beats by $0.20, revenue of $24.74M beats by $15.97M
Editas Medicine Inc.
NASDAQ: EDIT
EDIT Trading
2.45% G/L:
$2.67 Last:
1,085,358 Volume:
$2.61 Open:
EDIT Latest News
March 09, 2026 07:00:00 am
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
EDIT Stock Data
$174,737,401
95,568,668
0.4%
71
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
